Literature DB >> 7809057

Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases.

L Cohen1, R Mohr, Y Y Chen, M Huang, R Kato, D Dorin, F Tamanoi, A Goga, D Afar, N Rosenberg.   

Abstract

We report the characterization of a member of the ras gene family that is overexpressed in cells transformed by abl tyrosine kinase oncogenes. The gene, named kir (for kinase-inducible ras-like), is induced at the transcriptional level. kir mRNA has a rapid turnover and encodes a protein of 33 kDa with guanine nucleotide-binding activity but undetectable intrinsic GTPase activity. kir was cloned by differential screening of genes present in fully malignant versus growth factor-independent cell lines expressing wild-type or mutant forms of BCR/ABL. BCR/ABL and v-Abl induce transcription of the kir gene via specific signaling pathway(s), but kir overexpression alone is not sufficient to mediate transformation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809057      PMCID: PMC45455          DOI: 10.1073/pnas.91.26.12448

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.

Authors:  P Liang; A B Pardee
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

Review 2.  Primary response genes induced by growth factors and tumor promoters.

Authors:  H R Herschman
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

3.  Identification of effector residues and a neutralizing epitope of Ha-ras-encoded p21.

Authors:  I S Sigal; J B Gibbs; J S D'Alonzo; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

5.  Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates.

Authors:  R F Weaver; C Weissmann
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

6.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

7.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Authors:  A J Muller; J C Young; A M Pendergast; M Pondel; N R Landau; D R Littman; O N Witte
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

8.  An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.

Authors:  Y Y Chen; L C Wang; M S Huang; N Rosenberg
Journal:  Genes Dev       Date:  1994-03-15       Impact factor: 11.361

9.  SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.

Authors:  A M Pendergast; M L Gishizky; M H Havlik; O N Witte
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

10.  An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

Authors:  J B Konopka; S M Watanabe; O N Witte
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

View more
  30 in total

1.  Rem2, a new member of the Rem/Rad/Gem/Kir family of Ras-related GTPases.

Authors:  B S Finlin; H Shao; K Kadono-Okuda; N Guo; D A Andres
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

2.  The Ras-like GTPase Gem is involved in cell shape remodelling and interacts with the novel kinesin-like protein KIF9.

Authors:  E Piddini; J A Schmid; R de Martin; C G Dotti
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 3.  PseudoGTPase domains in p190RhoGAP proteins: a mini-review.

Authors:  Amy L Stiegler; Titus J Boggon
Journal:  Biochem Soc Trans       Date:  2018-12-04       Impact factor: 5.407

4.  Rem GTPase interacts with the proximal CaV1.2 C-terminus and modulates calcium-dependent channel inactivation.

Authors:  Chunyan Pang; Shawn M Crump; Ling Jin; Robert N Correll; Brian S Finlin; Jonathan Satin; Douglas A Andres
Journal:  Channels (Austin)       Date:  2010-05-01       Impact factor: 2.581

5.  Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases.

Authors:  Brian S Finlin; Shawn M Crump; Jonathan Satin; Douglas A Andres
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

6.  RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-beta.

Authors:  Ester Piek; Maarten Van Dinther; W Tony Parks; John M Sallee; Erwin P Böttinger; Anita B Roberts; Peter Ten Dijke
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 7.  The ß subunit of voltage-gated Ca2+ channels.

Authors:  Zafir Buraei; Jian Yang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 8.  The RGK family of GTP-binding proteins: regulators of voltage-dependent calcium channels and cytoskeleton remodeling.

Authors:  Robert N Correll; Chunyan Pang; Dana M Niedowicz; Brian S Finlin; Douglas A Andres
Journal:  Cell Signal       Date:  2007-11-06       Impact factor: 4.315

9.  Rin, a neuron-specific and calmodulin-binding small G-protein, and Rit define a novel subfamily of ras proteins.

Authors:  C H Lee; N G Della; C E Chew; D J Zack
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

10.  A novel 39-kilodalton membrane protein binds GTP in polyomavirus-transformed cells.

Authors:  P H Bauer; T L Benjamin
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.